Differential ovarian and testicular resistance to galactosaemia is perhaps due to the facts that expression of GALT is lowest in testis [39] that makes this organ less vulnerable to galactose toxicity, and that FSH does not play an obligatory role in the maintenance of spermatogenesis [40] unlike in folliculogenesis. The gene discussed is BRD2; the disease is galactosemia.